PTC (NASDAQ: PTC) will release its fiscal 2026 third quarter results on Wednesday, July 29 th after the stock market closes.
Zacks Investment Research on MSN
PTC Therapeutics (PTCT) upgraded to strong buy: Here's what you should know
PTC Therapeutics (PTCT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Barchart on MSN
PTC Inc. earnings preview: What to expect
PTC Inc. (PTC), headquartered in Boston, Massachusetts, develops and delivers technology solutions, comprised of software and ...
Curtiss-Wright Corporation CW has an Earnings ESP of +0.72% and a Zacks Rank #2 at present. CDW is scheduled to report ...
Index removals put fresh attention on PTC stock PTC (PTC) has just been removed from several Russell growth and factor ...
The partnership brings the Whatfix agentic digital adoption platform to users of PTC's product lifecycle management software ...
PTC Inc. (NasdaqGS:PTC) has been removed from multiple major Russell growth and benchmark indices. The changes affect ...
PTC Therapeutics is entering a new phase following the launch of Sephience, with expanding commercial efforts and pipeline ...
Hackers exploited a vulnerability in PTC Windchill in the wild, marking the first confirmed real-world abuse of the PLM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results